Periodic Reporting for period 1 - MAGI (Microbial therapy against gut inflammation)

Gut microbial dysbiosis have been associated with IBD, metabolic disorders and expansion of specific microbiota resident members that can drive inflammation (pathobionts). IBD affects over 5 million people world-wide, with estimate costs to healthcare of 4.6-5.6 thousand...